---
title: Cell and Gene Therapy Catapult vs eXmoor Pharma
slug_a: ct
slug_b: exmoorpharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/ct/exmoorpharma
---

# Cell and Gene Therapy Catapult vs eXmoor Pharma

Side-by-side profile data from each company listing on this directory.

## Cell and Gene Therapy Catapult

- Profile: [/companies/ct](/companies/ct)

Cell and Gene Therapy Catapult — UK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle.

Services: 13. Modalities: 3. Indications: 4. Locations: 5. Certifications: 0. The strongest documented coverage currently appears in services (13).

### Services

- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Viral Vector
- Single-Use / Disposable

## eXmoor Pharma

- Profile: [/companies/exmoorpharma](/companies/exmoorpharma)

eXmoor Pharma — Integrated cell and gene therapy CDMO with 20+ years of consultancy expertise, offering end-to-end CMC support from early-phase strategy through GMP manufacturing across viral vectors, autologous/allogeneic cell therapies, and RNA technologies.

Services: 9. Modalities: 3. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Viral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- mRNA Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- mRNA
- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Single-Use / Disposable